We are live on ! Find out more
TNB

Thomasville National Bank Portfolio holdings

AUM $1.82B
This Fund
S&P 500
This Quarter Est. Return
+2.07%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$547M
AUM Growth
+$44.2M
Cap. Flow
+$35.7M
Cap. Flow %
6.54%
Top 10 Hldgs %
28.45%
Holding
263
New
29
Increased
142
Reduced
52
Closed
13

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.9M
2
NVO
Novo Nordisk
NVO
+$2.63M
3
COR icon
Cencora
COR
+$2.62M
4
DGX icon
Quest Diagnostics
DGX
+$1.41M
5
RRC icon
Range Resources
RRC
+$1.29M

Sector Composition

Rank Sector Weight
1 Financials 16.09%
2 Healthcare 12.13%
3 Consumer Staples 10.51%
4 Industrials 9.83%
5 Technology 7.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRN
251
DELISTED
Veren
VRN
-11,500
Closed -$124K
MMP
252
DELISTED
Magellan Midstream Partners, L.P.
MMP
-2,760
Closed -$212K
BIVV
253
DELISTED
Bioverativ Inc. Common Stock
BIVV
-10,630
Closed -$579K
NSFC
254
DELISTED
NORTHERN STATES FINL CORP
NSFC
-37,185
Closed -$24K

Similar funds

Thomasville National Bank's Q2 2017 Portfolio in Review

As of Q2 2017, Thomasville National Bank held 263 positions worth $547M, up 8.8% from $503M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Thomasville National Bank deployed $35.7M of net new capital in Q2 2017, opening 29 new positions and adding to 142 existing holdings. Its largest new stake was Celgene Corp: 37,525 shares worth $4.87M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Gilead Sciences, an estimated $3.9M trimmed.

  • Thomasville National Bank's largest Q2 2017 buy was Celgene Corp: 37,525 shares worth $4.87M.
  • Thomasville National Bank added most to iShares Core S&P 500 ETF in Q2 2017, an estimated $10.1M increase.
  • Thomasville National Bank's biggest Q2 2017 reduction was Gilead Sciences, cutting an estimated $3.9M.
  • Thomasville National Bank fully exited Novo Nordisk in Q2 2017, selling an estimated $2.63M.
  • Thomasville National Bank's ten largest holdings make up 28% of its $547M portfolio in Q2 2017.
  • Thomasville National Bank opened 29 new positions and closed 13 in Q2 2017.
  • Thomasville National Bank's portfolio value rose 8.8% quarter-over-quarter to $547M.

Based on Thomasville National Bank's 13F filing for Q2 2017, filed 17 Jul 2017.